FDA cleared the Bonafix Implant Abutments from Zentek Medical, LLC on Oct 15, 2025 under K251294, a traditional 510(k). The device falls under product code NHA, Abutment, Implant, Dental, Endosseous, regulated at 21 CFR 872.3630 as a Class 2 device. The review panel was Dental.
FDA logged the submission as received on Apr 25, 2025. The decision came 173 days later, longer than the 90 FDA-day review goal, which usually means at least one additional information request.
This is the only decision on file for Zentek Medical, LLC in the last 12 months of the tracker.